Table: Kubota Pharmaceutical Holdings -2023 group forecast(SEC)
Jan 30 (Reuters) -
Kubota Pharmaceutical Holdings Co., Ltd.
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2023 Dec 31, 2023
LATEST PREVIOUS
FORECAST FORECAST
EPS loss 25.04 yen
Sales 40 mln
Operating loss 1.41
PreTax loss 1.39
Net loss 1.39
NOTE - Kubota Pharmaceutical Holdings Co., Ltd..
(Figures are reported based on U.S. accounting rules set by the U.S. securities
and Exchange Commission.)
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4596.T
Recent news on Kubota Pharmaceutical Holdings
See all newsTable: Kubota Pharmaceutical Holdings 6-MTH group results (IFRS)
Table: Kubota Pharmaceutical Holdings -Q1 group results (IFRS)
Brief: Kubota Vision Signs Supply & Licensing Agreement With Laboratoires Kôl
Table: Kubota Pharmaceutical Holdings -2025 parent results
Table: Kubota Pharmaceutical Holdings -2025 group results (IFRS)